INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

18,921 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
38
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
728 sh
Jan 28, 2026Jan 30, 2026
Page 342 of 474
← PrevNext →
traded Jan 28, 2026
+2d
SEC Form 4

Evidence

38
KW
Kucharski Brandt WalterChief Accounting Officer
LIFEEthos Technologies Inc.
Open-market sale
SELL$222K
12.4K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

38
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$80K
4,797 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

38
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$255K
21.5K sh
Nov 14, 2025Jan 30, 2026
traded Nov 14, 2025
+77dSEC Form 4

Evidence

37
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$586K
5,511 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

37
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$252K
2,304 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

37
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$322K
2,974 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

35
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$68K
6,000 sh
Nov 18, 2025Jan 30, 2026
traded Nov 18, 2025
+73dSEC Form 4

Evidence

35
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$89K
8,000 sh
Nov 19, 2025Jan 30, 2026
traded Nov 19, 2025
+72dSEC Form 4

Evidence

35
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$230K
19.0K sh
Nov 17, 2025Jan 30, 2026
traded Nov 17, 2025
+74dSEC Form 4

Evidence

34
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$72K
4,333 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

34
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$106K
949 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

34
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
1,031 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

33
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$1.22M
83.0K sh
Jan 12, 2026Jan 30, 2026
traded Jan 12, 2026
+18dSEC Form 4

Evidence

33
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$1.40M
96.9K sh
Jan 15, 2026Jan 30, 2026
traded Jan 15, 2026
+15dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$104K
10.0K sh
Nov 25, 2025Jan 30, 2026
traded Nov 25, 2025
+66dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$122K
12.0K sh
Nov 24, 2025Jan 30, 2026
traded Nov 24, 2025
+67dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$161K
17.2K sh
Dec 3, 2025Jan 30, 2026
traded Dec 3, 2025
+58dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$220K
22.0K sh
Dec 9, 2025Jan 30, 2026
traded Dec 9, 2025
+52dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$223K
22.0K sh
Dec 4, 2025Jan 30, 2026
traded Dec 4, 2025
+57dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.50M
14.2K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$81K
8,760 sh
Dec 2, 2025Jan 30, 2026
traded Dec 2, 2025
+59dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$23K
2,061 sh
Nov 20, 2025Jan 30, 2026
traded Nov 20, 2025
+71dSEC Form 4

Evidence

31
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
303 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

31
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$1,702
98 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

31
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$1,268
73 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$583K
56.2K sh
Jan 7, 2026Jan 30, 2026
traded Jan 7, 2026
+23dSEC Form 4

Evidence

30
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$150K
1,395 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$698K
54.1K sh
Jan 9, 2026Jan 30, 2026
traded Jan 9, 2026
+21dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$994K
82.3K sh
Jan 8, 2026Jan 30, 2026
traded Jan 8, 2026
+22dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$976K
66.5K sh
Jan 13, 2026Jan 30, 2026
traded Jan 13, 2026
+17dSEC Form 4

Evidence

30
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$526K
38.1K sh
Jan 14, 2026Jan 30, 2026
traded Jan 14, 2026
+16dSEC Form 4

Evidence

29
SE
Sindicich Michael EricPresident
NAVNNavan, Inc.
Open-market sale
SELL$126K
9,081 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

29
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$40K
4,000 sh
Dec 5, 2025Jan 30, 2026
traded Dec 5, 2025
+56dSEC Form 4

Evidence

29
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$30.75
3 sh
Nov 26, 2025Jan 30, 2026
traded Nov 26, 2025
+65dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$726K
6,939 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$380K
3,578 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

29
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$40K
4,002 sh
Dec 8, 2025Jan 30, 2026
traded Dec 8, 2025
+53dSEC Form 4

Evidence

27
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$1,529
88 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

27
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$394K
21.3K sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence